PartnerFacts
Data last updated: Oct 23, 2026, 5:45 PM ETLatest filing: Oct 22, 2026Now: Oct 24, 2026, 7:46 AM ET

Sponsor Check › Person

GJ
No photo found yet (own website and image search run after this page is viewed)

Gary Jacob

Named as an officer, director or promoter on SEC Form D filings · NY, CA, NJ · Mar 26, 2012 → Jun 23, 2020

3deals (issuers)
$49.4Mreported sold
118investors
19Form D filings
2012–2020years on file
Follow this personLook further ↓PDF

Data last updated Oct 23, 2026, 5:45 PM ET · Courts (RECAP) last checked: Oct 24, 2026, 2:25 AM ET · SEC enforcement last checked: covered by the index scan as of Oct 24, 2026, 2:50 AM ET

The short version

Gary Jacob is listed as an executive officer and director on 19 SEC Form D filings by 3 issuers between Jul 2009 and Oct 2023: Hepion Pharmaceuticals, Inc. (Red Bank, NJ — biotechnology — 2014–2023; $20M reported sold to 33 investors), SYNERGY PHARMACEUTICALS, INC. (New York, NY — biotechnology — 2009–2011; $15.9M reported sold to 45 investors) and Cardiff Oncology, Inc. (San Diego, CA — biotechnology — 2012–2020; $13.5M reported sold to 40 investors).

What this means A repeat sponsor — 3 separate companies raised money with this person listed as executive officer and director, over about 14 years. Across those companies the filings report $49.4M sold in total.

Listed alongside Thomas Adams (15 shared filings), John Brancaccio (9 shared filings), Rodney S. Markin (8 shared filings), Bernard Denoyer (5 shared filings), Gabriele M. Cerrone (5 shared filings) and 34 others.

What this means These are the other officers, directors or promoters the companies named on the same forms — the team around Gary. Each name links to their own page.

1 of the issuers belongs to the sponsor group Hepion (3 issuers, $4.28M reported sold, 2014–2026).

What this means A sponsor group is one team that sets up a new company for each deal. Hepion has 3 companies on file and $4.28M reported sold in total — the group page shows the whole track record in one place.

Public records searched: federal courts (CourtListener / RECAP), SEC enforcement releases, state securities regulators (AK, AL, AR, AZ, CA, CT, DE, FINRA, GA, HI, ID, IL, KS, KY, LA, MA, MD, ME, MI, MO, MS, MT, NASAA, NC, ND, NH, NM, NV, OK, OR, PA, RI, SC, SD, TN, TX, VT, WA, WI, WV, WY) — 1 court case matching the name, 6 bankruptcy cases matching the name listed in Key records below.

What this means 7 records came back. Each one is listed below with a link to the original document and a line saying why it matched. A name match is not proof it is the same person or company — read the why line and the document. Being sued or named in a release is an accusation, not a finding.

We compared 19 public filings for Gary Jacob and found 11 differences, 2 worth asking the sponsor about: 5 bankruptcy cases name the subject or team members; 4 Form Ds were filed more than 15 days after the first sale; and more below.

What this means These are differences between the sponsor's own SEC filings — both values, dates and sources are listed in Key records, section 4. Most have ordinary explanations; ask the sponsor.

What the community is saying

Community search for Gary Jacob has not run yet — it is joining a line of 27,050 names; searches run around the clock at the hosts' allowed rate. Searched so far: 638 names.

Community comments are quoted as written by their authors. Sources searched: BiggerPockets forums (via DuckDuckGo, Brave, Bing and BiggerPockets search) and Reddit (search feed + public archive).

Key records

Five things investors ask first. Items still in human review are counted, not shown.

1. Lawsuits

1 case: 1 dismissed

In Re: Gary T. Jacob dismissed
District Court, D. Nevada · No. 2:02-cv-01444 · Filed Oct 31, 2002 · Closed Feb 26, 2004 · Nature of suit: 422 Bankruptcy appeals rule 28 USC 158
Role of Gary T. Jacob: Party · Outcome: Terminated 2004-02-26 — FJC Integrated Database disposition: Dismissed: want of prosecution Docket on CourtListener ↗
same full name (a name found in 13 federal dockets); court in NV (not a filing state)
What was searched

Sources searched: CourtListener bulk data (RECAP dockets as of 2026-09-30; recall-first rule 10-24) — federal district + bankruptcy courts State courts: not covered (one-tap state court links under Look further). PACER: not searched. · Last checked Oct 24, 2026, 2:25 AM ET.

Court records show docket facts only; we never restate allegations as facts. Outcome wording comes from the docket feed; where it does not state a disposition we say so.

State courts: not covered (one-tap state court links under Look further). No state offers a lawful automated statewide source PartnerFacts can use today. Texas (re:SearchTX) terms prohibit storing results in a database open to third parties; New York (WebCivil) and Massachusetts (MassCourts) require a browser check that blocks scripted queries; California has no statewide index (58 county portals; Rule of Court 2.503 grants name-based access case by case); Florida, Utah and Illinois offer paid or partial access whose terms for automated use are unverified. Washington (dw.courts.wa.gov; bulk index reports under a JISC data-dissemination agreement), Delaware (CourtConnect; Court of Chancery not included) and Arizona (apps.azcourts.gov/publicaccess, which has an official channel to request high-volume access) are the candidates; PartnerFacts will request written permission before any automated search. Federal courts are searched through CourtListener / RECAP.

2. Regulatory actions

None found in sources searched — SEC enforcement releases (index scan as of Oct 24, 2026, 2:50 AM ET) · state securities regulators: VA (crawled Oct 23, 2026)

What was searched

SEC enforcement searched: SEC litigation releases and administrative proceedings — respondent names in the sec.gov index titles (30,205 releases, 1995-09-19 to 2026-10-23); release text is read only to confirm a candidate. Names that appear only in the body of a release are not found. — Searched SEC litigation releases and administrative proceedings (1995→ / 2007→) (30,205 records as of Oct 24, 2026, 2:50 AM ET) — nothing matched Gary Jacob..

State securities regulators: Securities regulators searched (3,318 actions): AZ Corporation Commission Securities Division (411 actions, 2017–2026), CA DFPI (25 actions, 2007–2024; listing starts 2002 — 16 of 12,159 DFPI respondent pages read so far; sponsor-name matches are read first), DE DOJ Investor Protection Unit (257 actions, 1987–2026), TX State Securities Board (586 actions, 2006–2026), WA DFI (2,039 actions, 2001–2026) — last crawled Oct 23, 2026, 9:57 PM ET. No machine-readable public listing today for CO, FL, IA, IN, MN, NE, NJ, NY, OH, UT, VA (see docs/state-regulators.md).

3. Bankruptcies

6 cases: 6 closed (disposition not in docket feed)

Gary W Jacob closed
United States Bankruptcy Court, N.D. Ohio · No. 08-40993 · Filed Apr 12, 2008 · Closed Aug 29, 2008
Role of Gary W Jacob: Debtor · Outcome: Case closed 2008-08-29 (disposition not included in the bulk docket feed — see docket) Docket on CourtListener ↗
same full name (a name found in 13 federal dockets); court in OH (not a filing state)
Gary Jacob and Diana Joy Jacob closed
United States Bankruptcy Court, D. New Jersey · No. 98-56291 · Filed Dec 22, 1998 · Closed Apr 29, 1999
Role of Gary Jacob and Diana Joy Jacob: Debtor · Outcome: Case closed 1999-04-29 (disposition not included in the bulk docket feed — see docket) Docket on CourtListener ↗
same full name (a name found in 13 federal dockets); court in the person's filing state (NJ)
GARY T. JACOB closed
United States Bankruptcy Court, D. Nevada · No. 98-21083 · Filed Feb 10, 1998 · Closed Oct 26, 2000
Role of GARY T. JACOB: Debtor · Outcome: Case closed 2000-10-26 (disposition not included in the bulk docket feed — see docket) Docket on CourtListener ↗
same full name (a name found in 13 federal dockets); court in NV (not a filing state)
Gary T. Jacob and Ronda Lee Jacob closed
United States Bankruptcy Court, D. North Dakota · No. 94-30624 · Filed Jul 11, 1994 · Closed Oct 25, 1994
Role of Gary T. Jacob and Ronda Lee Jacob: Debtor · Outcome: Case closed 1994-10-25 (disposition not included in the bulk docket feed — see docket) Docket on CourtListener ↗
same full name (a name found in 13 federal dockets); court in ND (not a filing state)
Gary L. Jacob and Patricia A. Jacob closed
United States Bankruptcy Court, E.D. Wisconsin · No. 93-25162 · Filed Sep 15, 1993 · Closed Jan 7, 1994
Role of Gary L. Jacob and Patricia A. Jacob: Debtor · Outcome: Case closed 1994-01-07 (disposition not included in the bulk docket feed — see docket) Docket on CourtListener ↗
same full name (a name found in 13 federal dockets); court in WI (not a filing state)
Gary R. Jacob and Karen L. Jacob closed
United States Bankruptcy Court, D. Massachusetts · No. 89-40688 · Filed Jul 31, 1989 · Closed Nov 30, 1989
Role of Gary R. Jacob and Karen L. Jacob: Debtor · Outcome: Case closed 1989-11-30 (disposition not included in the bulk docket feed — see docket) Docket on CourtListener ↗
same full name (a name found in 13 federal dockets); court in MA (not a filing state)
What was searched

Sources searched: Federal bankruptcy courts via CourtListener / RECAP archive (federal district courts, federal bankruptcy courts). State courts: not covered (one-tap state court links under Look further). PACER: not searched (RECAP only). · Last checked Oct 24, 2026, 2:25 AM ET.

Court records show docket facts only; we never restate allegations as facts. Outcome wording comes from the docket feed; where it does not state a disposition we say so.

State courts: not covered (one-tap state court links under Look further). No state offers a lawful automated statewide source PartnerFacts can use today. Texas (re:SearchTX) terms prohibit storing results in a database open to third parties; New York (WebCivil) and Massachusetts (MassCourts) require a browser check that blocks scripted queries; California has no statewide index (58 county portals; Rule of Court 2.503 grants name-based access case by case); Florida, Utah and Illinois offer paid or partial access whose terms for automated use are unverified. Washington (dw.courts.wa.gov; bulk index reports under a JISC data-dissemination agreement), Delaware (CourtConnect; Court of Chancery not included) and Arizona (apps.azcourts.gov/publicaccess, which has an official channel to request high-volume access) are the candidates; PartnerFacts will request written permission before any automated search. Federal courts are searched through CourtListener / RECAP.

4. Differences between public sources

Comparisons cover issuers and sponsor groups — see the issuer pages under Deals

11 differences found between the filings for Gary Jacob — 2 worth asking about (compared 19 filings on Oct 24, 2026)

Worth asking · Oct 8, 1998 – Dec 12, 2018

5 bankruptcy cases name the subject or team members

Bankruptcy case: Gary Jacob and Diana Joy Jacob — filed Dec 22, 1998 · Bankruptcy case: Synergy Pharmaceuticals Inc. and Certain former individual directors and officers o — filed Dec 12, 2018 · Bankruptcy case: Heritage Pacific Financial LLC v. Countouriotis — filed Nov 30, 2010 · Bankruptcy case: Christopher J. McGuigan — filed May 8, 2003 · Bankruptcy case: Christopher D. McGuigan — filed Oct 8, 1998

What this means A bankruptcy filing was found. Many are old or personal and have nothing to do with the deal — but ask what it was and when it closed.

Docket · United States Bankruptcy Court, D. New Jersey ↗Docket · United States Bankruptcy Court, S.D. New York ↗SYNERGY PHARMACEUTICALS, INC. — PartnerFacts page ↗Docket · United States Bankruptcy Court, E.D. California ↗
Sources
Worth asking · Feb 12, 2009 – Dec 7, 2012

4 Form Ds were filed more than 15 days after the first sale

Form D filed 1,020 days after the first sale — Cardiff Oncology, Inc. · Form D filed 148 days after the first sale — SYNERGY PHARMACEUTICALS, INC. · Form D filed 16 days after the first sale — Cardiff Oncology, Inc. · Form D filed 17 days after the first sale — SYNERGY PHARMACEUTICALS, INC.

What this means Late notices are common and carry no penalty by themselves. A pattern of late paperwork is worth asking the sponsor about.

Form D · Mar 26, 2012 ↗Cardiff Oncology, Inc. — PartnerFacts page ↗Form D · Jul 10, 2009 ↗SYNERGY PHARMACEUTICALS, INC. — PartnerFacts page ↗
Sources
Note · Feb 12, 2009 – Jul 24, 2017

6 offerings have no amendment in the last 12 months and may still be open

No amendment in the last 12 months on an offering that may still be open — Cardiff Oncology, Inc. (latest filing Jul 24, 2017) · No amendment in the last 12 months on an offering that may still be open — Hepion Pharmaceuticals, Inc. (latest filing Oct 23, 2014) · No amendment in the last 12 months on an offering that may still be open — Cardiff Oncology, Inc. (latest filing Dec 7, 2012) · No amendment in the last 12 months on an offering that may still be open — SYNERGY PHARMACEUTICALS, INC. (latest filing Jun 20, 2011) · No amendment in the last 12 months on an offering that may still be open — SYNERGY PHARMACEUTICALS, INC. (latest filing Aug 20, 2010) · and 1 more

What this means SEC rules expect a yearly amendment while an offering is still going. Ask the sponsor which of these raises have closed.

Form D · Jul 24, 2017 ↗Cardiff Oncology, Inc. — PartnerFacts page ↗Form D · Oct 23, 2014 ↗Hepion Pharmaceuticals, Inc. — PartnerFacts page ↗
Sources
Note · Feb 14, 2014 – Aug 22, 2014

Gary Jacob's role changed at Hepion Pharmaceuticals, Inc.: executive officer, director → director

The Feb 14, 2014 filing lists Gary Jacob as executive officer, director; the Aug 22, 2014 Form D lists director.

What this means Roles on Form D are self-reported by the issuer. A change can mean a real change in who runs the company, or just a different box ticked. Ask who makes decisions today.

Form D · Feb 14, 2014 ↗Form D · Aug 22, 2014 ↗Gary Jacob — PartnerFacts page ↗Hepion Pharmaceuticals, Inc. — PartnerFacts page ↗
Sources
Note · Jul 10, 2009 – Nov 18, 2009

Offering amount changed between filings — SYNERGY PHARMACEUTICALS, INC.

The Jul 10, 2009 filing says $14,000,000 offered; the Nov 18, 2009 Form D/A says $18,200,000.

What this means The target raise changed. Raising the cap is common when a deal grows; ask whether the extra money has the same terms and use.

Form D (earlier) · Jul 10, 2009 ↗Form D/A (later) · Nov 18, 2009 ↗SYNERGY PHARMACEUTICALS, INC. — PartnerFacts page ↗
Sources
Note · Jul 10, 2009 – Aug 20, 2010

Gary Jacob is written 2 different ways on the filings

listed as "Gary S. Jacob" on 7 filings (from Jul 10, 2009), and "Gary Jacob" on 12 filings (from Aug 20, 2010).

What this means Same person, written differently — a middle name or suffix left off, or spelled another way. It is normal, but check that the full legal name matches your subscription documents.

Form D · Jul 10, 2009 ↗Form D · Aug 20, 2010 ↗Gary Jacob — PartnerFacts page ↗
Sources
Note · Feb 14, 2014 – Oct 3, 2023

Industry group changed between filings — Hepion Pharmaceuticals, Inc.

"Biotechnology" (Feb 14, 2014 to Mar 27, 2019); then "Pharmaceuticals" (Oct 3, 2023).

What this means The issuer described its business differently on different forms. Often it is just a different box ticked; sometimes the deal itself changed. Ask which business your money is in.

Form D · Feb 14, 2014 ↗Form D · Oct 3, 2023 ↗Hepion Pharmaceuticals, Inc. — PartnerFacts page ↗
Sources
Note · Mar 26, 2012 – Apr 10, 2019

Reported revenue range changed between filings — Cardiff Oncology, Inc.

"$1 - $1,000,000" (Mar 26, 2012); then "Decline to Disclose" (Apr 10, 2019).

What this means This is the size band the issuer picks for itself on the form. A change can mean the business grew or shrank — or that it chose not to say. Ask for current numbers.

Form D · Mar 26, 2012 ↗Form D · Apr 10, 2019 ↗Cardiff Oncology, Inc. — PartnerFacts page ↗
Sources
Note · Feb 14, 2014 – Mar 27, 2019

Reported revenue range changed between filings — Hepion Pharmaceuticals, Inc.

"No Revenues" (Feb 14, 2014); then "Decline to Disclose" (Mar 27, 2019).

What this means This is the size band the issuer picks for itself on the form. A change can mean the business grew or shrank — or that it chose not to say. Ask for current numbers.

Form D · Feb 14, 2014 ↗Form D · Mar 27, 2019 ↗Hepion Pharmaceuticals, Inc. — PartnerFacts page ↗
Sources
Note · Aug 22, 2014 – Oct 23, 2014

Address moved from New York, NY to Edison, NJ — Hepion Pharmaceuticals, Inc.

The people listed on the Aug 22, 2014 filing give New York, NY; on the Oct 23, 2014 filing they give Edison, NJ.

What this means Businesses move; this just shows the two places and dates. If you were told one city and the forms say another, ask which is current.

Form D · Aug 22, 2014 ↗Form D · Oct 23, 2014 ↗Hepion Pharmaceuticals, Inc. — PartnerFacts page ↗
Sources
Note · Jul 10, 2009 – Oct 3, 2023

Gary Jacob is listed with 3 different address states: NY, CA, NJ

NY on 6 filings (Jul 10, 2009 to Aug 22, 2014); CA on 10 filings (Mar 26, 2012 to Jun 23, 2020); NJ on 3 filings (Oct 23, 2014 to Oct 3, 2023).

What this means The address on a Form D is usually the company's, not the person's home, so this often just reflects different companies. It can also mean a move. Nothing wrong by itself.

Form D · Jul 10, 2009 ↗Form D · Mar 26, 2012 ↗Form D · Oct 23, 2014 ↗
Sources
What is compared

What is compared: every Form D and D/A we hold for this subject, side by side — filing dates vs. first-sale dates (the 15-day rule), amendment timing on open offerings (the yearly-amendment expectation), amounts sold, investor counts, offering amounts and minimums across amendments, industry and size bands, addresses, how each person's name and role is written, paid sellers' CRD numbers, and (for groups) where the member companies were formed and sit. Everything is as filed by the issuer; the SEC does not check it. Differences are common and usually have ordinary explanations — we show both values, the dates, and the source so you can ask. As of Oct 24, 2026.

5. Money to insiders

5 of 18 offerings report sales commissions totalling $2,238,997; 2 report finder's fees totalling $285,000; 0 report proceeds to related persons. (includes amounts the issuer reported as estimates)

Offering (latest filing)Sales commissionsFinder's feesTo insidersPaid to sell itSource
Oct 3, 2023 D
Hepion Pharmaceuticals, Inc.
File 021-493729
$399,996$0$0A.G.P./Alliance Global Partners BrokerCheck CRD 8361 ↗EDGAR ↗
Jun 23, 2020 D
Cardiff Oncology, Inc.
File 021-369462
$0$0$0None listed on this filingEDGAR ↗
Jun 1, 2020 D
Cardiff Oncology, Inc.
File 021-368047
$0$0$0None listed on this filingEDGAR ↗
Apr 14, 2020 D
Cardiff Oncology, Inc.
File 021-364879
$0$0$0None listed on this filingEDGAR ↗
Oct 30, 2019 D
Cardiff Oncology, Inc.
File 021-352221
$1,150,000 (est.)$0$0H.C. Wainwright & Co., LLC BrokerCheck CRD 375 ↗EDGAR ↗
Aug 28, 2019 D
Cardiff Oncology, Inc.
File 021-347598
$0$0$0None listed on this filingEDGAR ↗
May 20, 2019 D
Cardiff Oncology, Inc.
File 021-339973
$0$0$0None listed on this filingEDGAR ↗
Apr 10, 2019 D
Cardiff Oncology, Inc.
File 021-336966
$0$0$0None listed on this filingEDGAR ↗
Mar 27, 2019 D
Hepion Pharmaceuticals, Inc.
File 021-335827
$0$0$0None listed on this filingEDGAR ↗
Jul 24, 2017 D
Cardiff Oncology, Inc.
File 021-291358
$427,214$50,000$0Maxim Group LLC BrokerCheck CRD 120708 ↗EDGAR ↗
Oct 23, 2014 D
Hepion Pharmaceuticals, Inc.
File 021-227046
$0$0$0None listed on this filingEDGAR ↗
Aug 22, 2014 D
Hepion Pharmaceuticals, Inc.
File 021-223509
$0$0$0None listed on this filingEDGAR ↗
Feb 14, 2014 D
Hepion Pharmaceuticals, Inc.
File 021-212036
$0$0$0 (est.)
In the ordinary course of business, the issuer may use some of the proceeds to pay salaries to its officers and directors.
None listed on this filingEDGAR ↗
Dec 7, 2012 D
Cardiff Oncology, Inc.
File 021-188012
$0$0$0None listed on this filingEDGAR ↗
Mar 26, 2012 D
Cardiff Oncology, Inc.
File 021-175603
$124,500$0$0
Issuer used proceeds from the offering for working capital purposes which included payment of salaries to named executive officers.
None listed on this filingEDGAR ↗
Jun 20, 2011 D
SYNERGY PHARMACEUTICALS, INC.
File 021-161496
$137,287$0$0Enclave Capital BrokerCheck CRD 22732 ↗EDGAR ↗
Aug 20, 2010 D
SYNERGY PHARMACEUTICALS, INC.
File 021-146769
$0$0$0None listed on this filingEDGAR ↗
Nov 18, 2009 D/A
SYNERGY PHARMACEUTICALS, INC.
File 021-84127
$0$235,000$0None listed on this filingEDGAR ↗
How this is counted

Counts come from Form D Items 12–15 on the filings in our index (latest filing per offering; one offering = one SEC file number; an amendment updates its offering rather than adding one). "To insiders" = gross proceeds used for payments to executive officers, directors or promoters. "—" = not reported on that filing. Amounts marked (est.) were reported as estimates. "Paid to sell it" = sales compensation recipients named on that filing (Item 12), each linked to FINRA BrokerCheck when a CRD number is reported.

Counted across every filing this person is listed on (latest filing per offering, per issuer).

Deals 3

Every issuer that named Gary Jacob on a Form D, newest first. A Form D is the notice a company files after it starts selling a private investment.

HP
Pharmaceuticals · group: Hepion

Hepion Pharmaceuticals, Inc.

Red Bank, NJ · Feb 14, 2014 → Oct 3, 2023 · 5 filings
  • Oct 3, 2023 · D · $5,000,004 sold of $5,000,004 · 1 investors · min. No minimum reported · role: Director EDGAR ↗
  • Mar 27, 2019 · D · $1,250,000 sold of $1,250,000 · 1 investors · min. No minimum reported · role: Director EDGAR ↗
  • Oct 23, 2014 · D · $9,000,000 sold of $12,500,000 · 1 investors · min. No minimum reported · role: Director EDGAR ↗
  • Aug 22, 2014 · D · $4,742,648 sold of $4,742,648 · 19 investors · min. No minimum reported · role: Director EDGAR ↗
  • Feb 14, 2014 · D · $3,225,000 sold of $3,225,000 · 19 investors · min. $25,000 · role: Executive Officer, Director EDGAR ↗

Raised $20M from 33 investors (100% of the $5M target) as of the latest filing. Gary is listed as director, executive officer on 5 filings for this deal.

Latest filing on EDGAR ↗
Sources

Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer. "Similar" = offerings in the same industry claiming the same exemption, filed in the last 5 years: Pharmaceuticals / 506(b) (800 filings); ranges are the middle half (25th–75th percentile). Computed by PartnerFacts from SEC EDGAR Form D data as of Oct 23, 2026, 5:45 PM ET. Rows without a range: fewer than 30 comparable filings, or not a Rule 506 offering. No ranking or score.

CO
Biotechnology

Cardiff Oncology, Inc.

San Diego, CA · Mar 26, 2012 → Jun 23, 2020 · 10 filings
  • Jun 23, 2020 · D · $13,500,000 sold of $13,500,000 · 3 investors · min. No minimum reported · role: Director EDGAR ↗
  • Jun 1, 2020 · D · $2,500,000 sold of $2,500,000 · 1 investors · min. No minimum reported · role: Director EDGAR ↗
  • Apr 14, 2020 · D · $2,084,000 sold of $2,084,000 · 1 investors · min. No minimum reported · role: Director EDGAR ↗
  • Oct 30, 2019 · D · $5,000,000 sold of $5,000,000 · 2 investors · min. No minimum reported · role: Director EDGAR ↗
  • Aug 28, 2019 · D · $1,500,000 sold of $1,500,000 · 1 investors · min. No minimum reported · role: Director EDGAR ↗
  • May 20, 2019 · D · $1,500,000 sold of $1,500,000 · 1 investors · min. No minimum reported · role: Director EDGAR ↗
  • Apr 10, 2019 · D · $1,500,000 sold of $1,500,000 · 1 investors · min. No minimum reported · role: Director EDGAR ↗
  • Jul 24, 2017 · D · $0 sold of $6,547,512 · 4 investors · min. No minimum reported · role: Director EDGAR ↗
  • Dec 7, 2012 · D · $3,760,000 sold of $4,420,000 · 8 investors · min. No minimum reported · role: Director EDGAR ↗
  • Mar 26, 2012 · D · $6,598,200 sold of $6,598,200 · 40 investors · min. No minimum reported · role: Director EDGAR ↗

Raised $13.5M from 40 investors (100% of the $13.5M target) as of the latest filing. Gary is listed as director on 10 filings for this deal.

Latest filing on EDGAR ↗
Sources

Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer. "Similar" = offerings in the same industry claiming the same exemption, filed in the last 5 years: Biotechnology / 506(b) (3,253 filings); ranges are the middle half (25th–75th percentile). Computed by PartnerFacts from SEC EDGAR Form D data as of Oct 23, 2026, 5:45 PM ET. Rows without a range: fewer than 30 comparable filings, or not a Rule 506 offering. No ranking or score.

SP
Biotechnology

SYNERGY PHARMACEUTICALS, INC.

New York, NY · Jul 10, 2009 → Jun 20, 2011 · 4 filings
  • Jun 20, 2011 · D · $1,161,243 sold of $2,161,243 · 9 investors · min. No minimum reported · role: Executive Officer, Director EDGAR ↗
  • Aug 20, 2010 · D · $400,000 sold of $15,000,000 · 1 investors · min. $25,000 · role: Executive Officer, Director EDGAR ↗
  • Nov 18, 2009 · D/A · $15,870,000 sold of $18,200,000 · 45 investors · min. No minimum reported · role: Executive Officer, Director EDGAR ↗
  • Jul 10, 2009 · D · $7,092,500 sold of $14,000,000 · 16 investors · min. No minimum reported · role: Executive Officer, Director EDGAR ↗

Raised $15.9M from 45 investors (100% of the $2.16M target) as of the latest filing. Gary is listed as executive officer, director on 4 filings for this deal.

Latest filing on EDGAR ↗
Sources

Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer.

People around Gary 39

Officers, directors, promoters and management entities named on the same filings, as of Oct 23, 2026, 5:45 PM ET.

TA
No photo found yet (own website and image search run after this page is viewed)
Person

Thomas Adams

Director, Executive Officer · 15 shared filings (3 issuers) · also on 2 other issuers

Thomas Adams is on 5 issuers in total — a repeat sponsor. Their page lists every one.

JB
No photo found yet (own website and image search run after this page is viewed)
Person

John Brancaccio

Director · 9 shared filings (1 issuer) · also on 1 other issuer

Listed on the same filings as Gary Jacob. Their page shows their other deals.

RM
No photo found yet (own website and image search run after this page is viewed)
Person

Rodney S. Markin

Director · 8 shared filings (1 issuer) · also on 3 other issuers

Listed on the same filings as Gary Jacob. Their page shows their other deals.

BD
No photo found yet (own website and image search run after this page is viewed)
Person

Bernard Denoyer

Executive Officer, Director · 5 shared filings (2 issuers)

Listed on the same filings as Gary Jacob. Their page shows their other deals.

GC
No photo found yet (own website and image search run after this page is viewed)
Person

Gabriele M. Cerrone

Director · 5 shared filings (2 issuers)

Listed on the same filings as Gary Jacob. Their page shows their other deals.

TB
No photo found yet (own website and image search run after this page is viewed)
Person

Timothy Block

Director · 5 shared filings (1 issuer)

Listed on the same filings as Gary Jacob. Their page shows their other deals.

KS
No photo found yet (own website and image search run after this page is viewed)
Person

Kunwar Shailubhai

Executive Officer · 4 shared filings (1 issuer) · also on 1 other issuer

Listed on the same filings as Gary Jacob. Their page shows their other deals.

MS
No photo found yet (own website and image search run after this page is viewed)
Person

Melvin K. Spigelman

Director · 4 shared filings (1 issuer)

Listed on the same filings as Gary Jacob. Their page shows their other deals.

CM
No photo found yet (own website and image search run after this page is viewed)
Person

Christopher McGuigan

Director · 4 shared filings (2 issuers)

Listed on the same filings as Gary Jacob. Their page shows their other deals.

JB
No photo found yet (own website and image search run after this page is viewed)
Person

John Brancaccio

Director · 4 shared filings (2 issuers) · also on 5 other issuers

John Brancaccio is on 7 issuers in total — a repeat sponsor. Their page lists every one.

AC
No photo found yet (own website and image search run after this page is viewed)
Person

Athena Countouriotis

Director · 4 shared filings (1 issuer) · also on 4 other issuers

Athena Countouriotis is on 5 issuers in total — a repeat sponsor. Their page lists every one.

ME
No photo found yet (own website and image search run after this page is viewed)
Person

Mark Erlander

Executive Officer, Director · 4 shared filings (1 issuer)

Listed on the same filings as Gary Jacob. Their page shows their other deals.

ST
No photo found yet (own website and image search run after this page is viewed)
Person

Stanley Tennant

Director · 3 shared filings (1 issuer)

Listed on the same filings as Gary Jacob. Their page shows their other deals.

JA
No photo found yet (own website and image search run after this page is viewed)
Person

James O. Armitage

Director · 3 shared filings (1 issuer)

Listed on the same filings as Gary Jacob. Their page shows their other deals.

LW
No photo found yet (own website and image search run after this page is viewed)
Person

Lale White

Director · 3 shared filings (1 issuer) · also on 1 other issuer

Listed on the same filings as Gary Jacob. Their page shows their other deals.

GP
No photo found yet (own website and image search run after this page is viewed)
Person

Gary W. Pace

Director · 3 shared filings (1 issuer)

Listed on the same filings as Gary Jacob. Their page shows their other deals.

AS
No photo found yet (own website and image search run after this page is viewed)
Person

Antonius Schuh

Executive Officer, Director · 2 shared filings (1 issuer) · also on 3 other issuers

Listed on the same filings as Gary Jacob. Their page shows their other deals.

JS
No photo found yet (own website and image search run after this page is viewed)
Person

James Sapirstein

Executive Officer, Director · 2 shared filings (1 issuer) · also on 6 other issuers

James Sapirstein is on 7 issuers in total — a repeat sponsor. Their page lists every one.

BH
No photo found yet (own website and image search run after this page is viewed)
Person

Bill Hornung

Executive Officer · 2 shared filings (1 issuer)

Listed on the same filings as Gary Jacob. Their page shows their other deals.

JC
No photo found yet (own website and image search run after this page is viewed)
Person

John Cavan

Executive Officer · 2 shared filings (1 issuer)

Listed on the same filings as Gary Jacob. Their page shows their other deals.

RF
No photo found yet (own website and image search run after this page is viewed)
Person

Robert Foster

Executive Officer, Director · 2 shared filings (1 issuer)

Listed on the same filings as Gary Jacob. Their page shows their other deals.

JB
No photo found yet (own website and image search run after this page is viewed)
Person

John P. Brancaccio

Director · 2 shared filings (1 issuer) · also on 1 other issuer

Listed on the same filings as Gary Jacob. Their page shows their other deals.

AJ
No photo found yet (own website and image search run after this page is viewed)
Person

Alan Joslyn

Director · 2 shared filings (1 issuer)

Listed on the same filings as Gary Jacob. Their page shows their other deals.

SZ
No photo found yet (own website and image search run after this page is viewed)
Person

Steve Zaniboni

Executive Officer · 1 shared filing (1 issuer) · also on 2 other issuers

Listed on the same filings as Gary Jacob. Their page shows their other deals.

PB
No photo found yet (own website and image search run after this page is viewed)
Person

Paul Billings

Director · 1 shared filing (1 issuer) · also on 3 other issuers

Listed on the same filings as Gary Jacob. Their page shows their other deals.

GC
No photo found yet (own website and image search run after this page is viewed)
Person

Gabriel M Cerrone

Director · 1 shared filing (1 issuer)

Listed on the same filings as Gary Jacob. Their page shows their other deals.

CM
No photo found yet (own website and image search run after this page is viewed)
Person

Chris McGuigan

Director · 1 shared filing (1 issuer)

Listed on the same filings as Gary Jacob. Their page shows their other deals.

SZ
No photo found yet (own website and image search run after this page is viewed)
Person

Steve Zanibobi

Executive Officer · 1 shared filing (1 issuer)

Listed on the same filings as Gary Jacob. Their page shows their other deals.

WW
No photo found yet (own website and image search run after this page is viewed)
Person

William Welch

Executive Officer, Director · 1 shared filing (1 issuer) · also on 1 other issuer

Listed on the same filings as Gary Jacob. Their page shows their other deals.

BL
No photo found yet (own website and image search run after this page is viewed)
Person

Brigitte Lindsay

Executive Officer · 1 shared filing (1 issuer)

Listed on the same filings as Gary Jacob. Their page shows their other deals.

PW
No photo found yet (own website and image search run after this page is viewed)
Person

Petrus Wijngaard

Director · 1 shared filing (1 issuer)

Listed on the same filings as Gary Jacob. Their page shows their other deals.

KL
No photo found yet (own website and image search run after this page is viewed)
Person

Kaouthar Lbiati

Director · 1 shared filing (1 issuer)

Listed on the same filings as Gary Jacob. Their page shows their other deals.

AR
No photo found yet (own website and image search run after this page is viewed)
Person

Anand Reddi

Director · 1 shared filing (1 issuer)

Listed on the same filings as Gary Jacob. Their page shows their other deals.

DR
No photo found yet (own website and image search run after this page is viewed)
Person

DAVID I ROBBINS

Executive Officer · 1 shared filing (1 issuer) · also on 4 other issuers

DAVID I ROBBINS is on 5 issuers in total — a repeat sponsor. Their page lists every one.

JB
No photo found yet (own website and image search run after this page is viewed)
Person

John K. Brancaccio

Director · 1 shared filing (1 issuer)

Listed on the same filings as Gary Jacob. Their page shows their other deals.

JB
No photo found yet (own website and image search run after this page is viewed)
Person

John P. Brancaccio

Director · 1 shared filing (1 issuer) · also on 1 other issuer

Listed on the same filings as Gary Jacob. Their page shows their other deals.

JB
No photo found yet (own website and image search run after this page is viewed)
Person

John P. Brancaccio

Director · 1 shared filing (1 issuer)

Listed on the same filings as Gary Jacob. Their page shows their other deals.

JB
No photo found yet (own website and image search run after this page is viewed)
Person

John Brancaccio

Director · 1 shared filing (1 issuer) · also on 1 other issuer

Listed on the same filings as Gary Jacob. Their page shows their other deals.

AL
No photo found yet (own website and image search run after this page is viewed)
Person

Arnold Lippa

Director · 1 shared filing (1 issuer)

Listed on the same filings as Gary Jacob. Their page shows their other deals.

The team behind the deals

H
Sponsor group

Hepion

3 issuers · 15 filings · $4.28M reported sold · 2014–2026

One team, 3 deal companies. Gary Jacob is listed on 1 of them.

Sources

Issuers are grouped when their Form D filings share related persons, a management entity or a business address (automatic match from the filings). "Listed" marks the issuers that name Gary Jacob.

Same business address

51 other issuers file from the same address (first 50 shown)

A shared address can mean the same team, a shared office building or a registered agent. It is a lead, not a conclusion.

Registrations and other filings

Adviser registration (Form ADV)

None of the 3 issuers this person is listed on appears in Form ADV (searched 24,962 advisers as of Oct 2, 2026). A person is never an adviser firm; Form ADV is checked for the issuers and the management companies they are listed with.

Other offering types (Regulation A and Regulation Crowdfunding)

Searched SEC Regulation A Data Sets (Forms 1-A, 1-K, 1-Z; 2015 Q2 → 2026 Q3); SEC Crowdfunding Offerings Data Sets (Form C family; 2016 Q2 → 2026 Q3); EDGAR form index for 2026 Q3 → 2026 Q4 (51,358 records as of Oct 23, 2026, 8:41 PM ET) — nothing matched this name.

Property records none — individuals are not matched

Property records are matched to companies only, never to individuals, so none are matched to Gary Jacob by design. Searched property records in Hillsborough County FL (Clerk recorded-document index Oct 14, 2026 to Oct 15, 2026 + FL DOR 2026 ownership roll), Miami-Dade County FL (FL DOR 2026 ownership roll), Harris County TX (HCAD 2026 ownership roll), Dallas County TX (DCAD 2026 ownership roll), New York City ACRIS documents and PLUTO ownership rows already retrieved for other issuers, Cook County IL sale and ownership rows already retrieved for other issuers (814,874 records as of Oct 23, 2026, 8:59 PM ET) for the 3 issuers this person is listed on — nothing matched.

Public profiles and social

Websites and social links of the issuers Gary Jacob is listed on: none on file. No website or social profile named in SYNERGY PHARMACEUTICALS, INC.'s SEC filings (Form C, Reg A, Form ADV; checked Oct 24, 2026). Web search for this name: #350,609 of 374,652 in line (1,325 issuers searched so far). One-tap searches: Look further ↓

Look further

One-tap searches on sites we do not index ourselves, with the name pre-filled (New York, NY). Each opens in a new tab; what you find there is not verified by PartnerFacts.

Social and web

LinkedIn people search ↗Instagram ↗X (Twitter) ↗Facebook ↗YouTube ↗Google ↗Google Images ↗Google News ↗Meta Ad Library ↗

Courts

CourtListener / RECAP (federal) ↗PACER case locator (federal, login) ↗New York WebCivil Supreme ↗California — find the county court ↗Los Angeles Superior Court case search ↗New Jersey state courts — find the court ↗

Securities regulators

SEC EDGAR full-text search ↗SEC action look-up ↗FINRA BrokerCheck ↗SEC IAPD adviser search ↗

Business registries

New York Secretary of State business search ↗California Secretary of State business search ↗New Jersey Secretary of State business search ↗OpenCorporates ↗

Change history

No corrections have been requested for this page.

Every fact links to its public-record source. Plain-English notes next to a fact are our reading of that fact, not a rating. Request a correction · Facts policy

Request a correction

Free. Logged with status: received → under review → fixed / confirmed with source.

Add a response

If this is you or your firm, add a sourced explanation next to any fact. Reviewed before publishing.

Monitor this person

Members get an email when Gary Jacob appears on a new Form D, or when a court case or SEC action is matched to them. See plans →